NEW YORK (GenomeWeb News) – GE today said that it has named Sue Siegel, a former president of Affymetrix, to serve as CEO of its healthymagination initiative.

Siegel joins GE from Mohr Davidow Ventures, where she was a general partner leading investments in technology paltforms such as molecular diagnostics and digital health. She takes over the CEO role from Mike Barber, who led the initiative since 2009 but has been named VP and general manager of molecular imaging at GE Healthcare.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.